314 related articles for article (PubMed ID: 16509861)
1. Ratio of circulating follistatin and activin A reflects the severity of acute liver injury and prognosis in patients with acute liver failure.
Lin SD; Kawakami T; Ushio A; Sato A; Sato S; Iwai M; Endo R; Takikawa Y; Suzuki K
J Gastroenterol Hepatol; 2006 Feb; 21(2):374-80. PubMed ID: 16509861
[TBL] [Abstract][Full Text] [Related]
2. Activin A and follistatin in acute liver failure.
Hughes RD; Evans LW
Eur J Gastroenterol Hepatol; 2003 Feb; 15(2):127-31. PubMed ID: 12560755
[TBL] [Abstract][Full Text] [Related]
3. [Study on the relationship between activin A, follistatin and preeclampsia].
Zhao L; Shang T; Wang YL; Tang S; Li H; Liu ZH
Zhonghua Fu Chan Ke Za Zhi; 2003 Nov; 38(11):676-9. PubMed ID: 14728855
[TBL] [Abstract][Full Text] [Related]
4. Uterine vein and maternal urinary levels of activin A and inhibin A in pre-eclampsia patients.
Muttukrishna S; Hyett J; Paine M; Moodley J; Groome N; Rodeck C
Clin Endocrinol (Oxf); 2006 Apr; 64(4):469-73. PubMed ID: 16584522
[TBL] [Abstract][Full Text] [Related]
5. Follistatin-controlled activin-HNF4α-coagulation factor axis in liver progenitor cells determines outcome of acute liver failure.
Lin T; Wang S; Munker S; Jung K; Macías-Rodríguez RU; Ruiz-Margáin A; Schierwagen R; Liu H; Shao C; Fan C; Feng R; Yuan X; Wang S; Wandrer F; Meyer C; Wimmer R; Liebe R; Kroll J; Zhang L; Schiergens T; Ten Dijke P; Teufel A; Marx A; Mertens PR; Wang H; Ebert MPA; Bantel H; N De Toni E; Trebicka J; Dooley S; Shin D; Ding H; Weng HL
Hepatology; 2022 Feb; 75(2):322-337. PubMed ID: 34435364
[TBL] [Abstract][Full Text] [Related]
6. Potential anti-inflammatory role of activin A in acute coronary syndromes.
Smith C; Yndestad A; Halvorsen B; Ueland T; Waehre T; Otterdal K; Scholz H; Endresen K; Gullestad L; Frøland SS; Damås JK; Aukrust P
J Am Coll Cardiol; 2004 Jul; 44(2):369-75. PubMed ID: 15261933
[TBL] [Abstract][Full Text] [Related]
7. Possible contribution of serum activin A and IGF-1 in the development of hepatocellular carcinoma in Egyptian patients suffering from combined hepatitis C virus infection and hepatic schistosomiasis.
Elsammak MY; Amin GM; Khalil GM; Ragab WS; Abaza MM
Clin Biochem; 2006 Jun; 39(6):623-9. PubMed ID: 16624274
[TBL] [Abstract][Full Text] [Related]
8. Serum hepatocyte growth factor and vascular endothelial growth factor in children with acute liver failure.
Aw MM; Mitry RR; Hughes RD; Dhawan A
J Pediatr Gastroenterol Nutr; 2007 Feb; 44(2):224-7. PubMed ID: 17255836
[TBL] [Abstract][Full Text] [Related]
9. Reduced monocyte HLA-DR expression: a novel biomarker of disease severity and outcome in acetaminophen-induced acute liver failure.
Antoniades CG; Berry PA; Davies ET; Hussain M; Bernal W; Vergani D; Wendon J
Hepatology; 2006 Jul; 44(1):34-43. PubMed ID: 16799971
[TBL] [Abstract][Full Text] [Related]
10. Nucleosome serum levels in acute hepatic failure and MARS treatment.
Roth GA; Lubsczyk BA; Pilz J; Faybik P; Hetz H; Krenn CG
Transplant Proc; 2009 Dec; 41(10):4207-10. PubMed ID: 20005370
[TBL] [Abstract][Full Text] [Related]
11. Tumour necrosis factor-alpha and soluble Fas ligand as biomarkers in non-acetaminophen-induced acute liver failure.
Singhal S; Chakravarty A; Das BC; Kar P
Biomarkers; 2009 Aug; 14(5):347-53. PubMed ID: 19505222
[TBL] [Abstract][Full Text] [Related]
12. Serum levels of stem cell factor and thrombopoietin are markedly decreased in fulminant hepatic failure patients with a poor prognosis.
Okumoto K; Saito T; Onodera M; Sakamoto A; Tanaka M; Hattori E; Haga H; Ito JI; Sugahara K; Saito K; Togashi H; Kawata S
J Gastroenterol Hepatol; 2007 Aug; 22(8):1265-70. PubMed ID: 17688667
[TBL] [Abstract][Full Text] [Related]
13. Deregulation of the activin/follistatin system in hepatocarcinogenesis.
Grusch M; Drucker C; Peter-Vörösmarty B; Erlach N; Lackner A; Losert A; Macheiner D; Schneider WJ; Hermann M; Groome NP; Parzefall W; Berger W; Grasl-Kraupp B; Schulte-Hermann R
J Hepatol; 2006 Nov; 45(5):673-80. PubMed ID: 16935389
[TBL] [Abstract][Full Text] [Related]
14. Activin A and follistatin in systemic inflammation.
Jones KL; de Kretser DM; Patella S; Phillips DJ
Mol Cell Endocrinol; 2004 Oct; 225(1-2):119-25. PubMed ID: 15451576
[TBL] [Abstract][Full Text] [Related]
15. Serum apoptosis markers in acute liver failure: a pilot study.
Rutherford AE; Hynan LS; Borges CB; Forcione DG; Blackard JT; Lin W; Gorman AR; Shaikh OS; Reuben A; Harrison E; Reddy KR; Le WM; Chung RT;
Clin Gastroenterol Hepatol; 2007 Dec; 5(12):1477-83. PubMed ID: 17967565
[TBL] [Abstract][Full Text] [Related]
16. Maternal serum activin A and the prediction of intrauterine growth restriction.
Barkehall-Thomas A; Tong S; Baker LS; Edwards A; Wallace EM
Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):97-101. PubMed ID: 16638029
[TBL] [Abstract][Full Text] [Related]
17. Maternal serum inhibin-A and activin-A levels in the first trimester of pregnancies developing pre-eclampsia.
Spencer K; Cowans NJ; Nicolaides KH
Ultrasound Obstet Gynecol; 2008 Oct; 32(5):622-6. PubMed ID: 18816493
[TBL] [Abstract][Full Text] [Related]
18. Soluble CD163 in patients with liver diseases: very high levels of soluble CD163 in patients with fulminant hepatic failure.
Hiraoka A; Horiike N; Akbar SM; Michitaka K; Matsuyama T; Onji M
J Gastroenterol; 2005 Jan; 40(1):52-6. PubMed ID: 15692789
[TBL] [Abstract][Full Text] [Related]
19. betaA- and betaC-activin, follistatin, activin receptor mRNA and betaC-activin peptide expression during rat liver regeneration.
Gold EJ; Zhang X; Wheatley AM; Mellor SL; Cranfield M; Risbridger GP; Groome NP; Fleming JS
J Mol Endocrinol; 2005 Apr; 34(2):505-15. PubMed ID: 15821113
[TBL] [Abstract][Full Text] [Related]
20. Activation of hepatocyte growth factor/activin A/follistatin system during hemodialysis: role of heparin.
Borawski J; Naumnik B; Myśliwiec M
Kidney Int; 2003 Dec; 64(6):2229-37. PubMed ID: 14633147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
